ZORECIMERAN
UNII 5TP24STD1S

Substance Identification & Data

This profile provides standardized clinical and technical data for Zorecimeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5TP24STD1S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2432957-15-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5TP24STD1S

CAS Registry Number

2432957-15-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZORECIMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173851

National Cancer Institute reference terminology for clinical and research data.

INN ID

11868

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zorecimeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZORECIMERAN

Common Names & Synonyms

CUREVAC MRNA-BASED VACCINE IMMUNOGEN CANDIDATE AGAINST COVID-19

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH CODON-OPTIMISED PRE-FUSION STABILIZED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; NC_045512.2) SPIKE (S) GLYCOPROTEIN, FLANKED BY 5' AND 3' UNTRANSLATED REGIONS; THE 3' UNTRANSLATED REGION COMPRISES A PART OF THE HUMAN ALPHA GLOBIN GENE 3' UTR SEQUENCE ELEMENT, A SYNTHETIC POLY(A) TAIL AND A POLY(C)-RICH SEQUENCE FOLLOWED BY A HISTONE STEM LOOP SEQUENCE AS A 3' TAIL. IMMUNOLOGICAL AGENT FOR ACTIVE IMMUNIZATION (ANTI-SARS-COV-2)

RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-AM)-CAPPED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (986-PROLINE,987-PROLINE)-SPECIFYING 3'-TAILED MESSENGER R9515), INNER SALT

ZORECIMERAN [INN]

ZORECIMERAN [WHO-DD]